Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

VIVOS INC

RDGL · OTC · CIK 0001449349 · Healthcare · Medical Devices

INSIDER SIGNAL

49.4 / 100

2 buyers · 12 purchase transaction lines · $46.5K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleModerate
RecencyModerate
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+14.0 / 35
Purchase size+5.0 / 25
Role+13.0 / 20
Recency+7.4 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: CEO AND PRESIDENT (CEO, chair and 10% owners score lowest)
  • ✓ Recent activity · latest purchase 2026-09-30

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Weeks Brad AllanPresident
○●●●●●●●●
Korenko Michael KCEO AND PRESIDENT
●●●●
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION88%Largest buyer: Korenko Michael K · $128.1K
CLUSTER BUYING · 15D2 insidersPeak activity: 2026-07-09–2026-07-22

Roles in the peak window: CEO AND PRESIDENT, President. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

49.4 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 50.2
  2. 50.0
  3. 49.8
  4. 49.6
  5. 49.4

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

15Purchases
0Sales
3Other Form 4 lines
13SEC filings · 365 days
BUYING12 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER1 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-2.1%
3M
-17.7%
6M
-38.7%
12M
-42.9%

Volatility & liquidity

Volatility
98.1%
Beta
—
Avg daily value
USD 53,628

Valuation

Market cap
USD 24.0M
P/E
—

Fundamentals

Profit margin
—
ROE
-184.6%
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-12 · Status: PASS

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30Korenko Michael KPurchase (P)Common Stock200,000USD 0.50USD 99,600SEC filing ↗
2026-09-16Weeks Brad AllanPurchase (P)Common Stock25,550USD 0.05USD 1,278SEC filing ↗
2026-08-10Weeks Brad AllanPurchase (P)Common Stock50,000USD 0.05USD 2,500SEC filing ↗
2026-08-10Korenko Michael KPurchase (P)Common Stock150,000USD 0.05USD 7,500SEC filing ↗
2026-07-22Weeks Brad AllanPurchase (P)Common Stock32,000USD 0.05USD 1,600SEC filing ↗
2026-07-21Weeks Brad AllanPurchase (P)Common Stock60,000USD 0.05USD 3,000SEC filing ↗
2026-07-15Korenko Michael KPurchase (P)Common Stock200,000USD 0.06USD 12,000SEC filing ↗
2026-07-10Weeks Brad AllanPurchase (P)Common Stock12,000USD 0.08USD 960SEC filing ↗
2026-07-10Weeks Brad AllanPurchase (P)Common Stock12,000USD 0.08USD 960SEC filing ↗
2026-07-09Weeks Brad AllanPurchase (P)Common Stock48,000USD 0.08USD 3,840SEC filing ↗
2026-07-09Weeks Brad AllanPurchase (P)Common Stock48,000USD 0.08USD 3,840SEC filing ↗
2026-05-11Korenko Michael KPurchase (P)Common Stock150,000USD 0.06USD 9,000SEC filing ↗
2025-12-31Korenko Michael KPurchase (P)Common Stock200,000USD 0.06USD 12,000SEC filing ↗
2025-12-02Korenko Michael KPurchase (P)Common Stock100,000USD 0.07USD 7,000SEC filing ↗
2025-11-20Korenko Michael KPurchase (P)Common Stock100,000USD 0.06USD 6,000SEC filing ↗

Form 4 evidence

18 transaction lines in the latest 365-day window; 50 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30Korenko Michael KPurchase (P)Common Stock200,000USD 0.50USD 99,600SEC filing ↗
2026-09-16Weeks Brad AllanPurchase (P)Common Stock25,550USD 0.05USD 1,278SEC filing ↗
2026-08-10Weeks Brad AllanPurchase (P)Common Stock50,000USD 0.05USD 2,500SEC filing ↗
Show recent Form 4 evidence (18 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30Korenko Michael KPurchase (P)Common Stock200,000USD 0.50USD 99,600SEC filing ↗
2026-09-16Weeks Brad AllanPurchase (P)Common Stock25,550USD 0.05USD 1,278SEC filing ↗
2026-08-10Weeks Brad AllanPurchase (P)Common Stock50,000USD 0.05USD 2,500SEC filing ↗
2026-08-10Korenko Michael KPurchase (P)Common Stock150,000USD 0.05USD 7,500SEC filing ↗
2026-07-22Weeks Brad AllanPurchase (P)Common Stock32,000USD 0.05USD 1,600SEC filing ↗
2026-07-21Weeks Brad AllanPurchase (P)Common Stock60,000USD 0.05USD 3,000SEC filing ↗
2026-07-15Korenko Michael KPurchase (P)Common Stock200,000USD 0.06USD 12,000SEC filing ↗
2026-07-10Weeks Brad AllanPurchase (P)Common Stock12,000USD 0.08USD 960SEC filing ↗
2026-07-10Weeks Brad AllanPurchase (P)Common Stock12,000USD 0.08USD 960SEC filing ↗
2026-07-09Weeks Brad AllanPurchase (P)Common Stock48,000USD 0.08USD 3,840SEC filing ↗
2026-07-09Weeks Brad AllanPurchase (P)Common Stock48,000USD 0.08USD 3,840SEC filing ↗
2026-06-30Weeks Brad AllanAward / grant (A)Common Stock147,159USD 0.00USD 0SEC filing ↗
2026-05-11Korenko Michael KPurchase (P)Common Stock150,000USD 0.06USD 9,000SEC filing ↗
2026-03-31Weeks Brad AllanAward / grant (A)Common Stock100,111USD 0.00USD 0SEC filing ↗
2025-12-31Korenko Michael KPurchase (P)Common Stock200,000USD 0.06USD 12,000SEC filing ↗
2025-12-16Weeks Brad AllanAward / grant (A)Common Stock100,000USD 0.00USD 0SEC filing ↗
2025-12-02Korenko Michael KPurchase (P)Common Stock100,000USD 0.07USD 7,000SEC filing ↗
2025-11-20Korenko Michael KPurchase (P)Common Stock100,000USD 0.06USD 6,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRDGL
CIK0001449349
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeOTC

Data coverage

Local Form 4 history50 transaction lines from 2020-02-26 to 2026-09-30
37 P purchase lines · 2 S sale lines · 11 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.